Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Merck
Baxter
Medtronic
Dow

Last Updated: December 2, 2022

Hydrocortisone sodium succinate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for hydrocortisone sodium succinate and what is the scope of freedom to operate?

Hydrocortisone sodium succinate is the generic ingredient in three branded drugs marketed by Abbott, Hospira, Abraxis Pharm, Baxter Hlthcare, Intl Medication, Watson Labs, and Pharmacia And Upjohn, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for hydrocortisone sodium succinate. Three suppliers are listed for this compound.

Summary for hydrocortisone sodium succinate
Recent Clinical Trials for hydrocortisone sodium succinate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
ServierPhase 1
AbbViePhase 1
Andrew E. PlacePhase 1

See all hydrocortisone sodium succinate clinical trials

Pharmacology for hydrocortisone sodium succinate

US Patents and Regulatory Information for hydrocortisone sodium succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 088667-001 Jun 8, 1984 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Abraxis Pharm HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 088669-001 Jun 8, 1984 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Abraxis Pharm HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 088668-001 Jun 8, 1984 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Abbott A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 089578-001 Apr 11, 1989 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Watson Labs HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 084738-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hospira A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 085930-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Dow
AstraZeneca
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.